CAPTRUST Financial Advisors
MYGN icon

CAPTRUST Financial Advisors’s Myriad Genetics MYGN Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
25,261
+11,040
+78% +$50.1K ﹤0.01% 2971
2026
Q1 		$64K Sell
14,221
-3,823
-21% -$19.9K ﹤0.01% 2874
2025
Q4 		$111K Buy
18,044
+3,782
+27% +$27.4K ﹤0.01% 2600
2025
Q3 		$103K Buy
+14,262
New +$84.7K ﹤0.01% 2507
2025
Q2 		– Sell
-26,678
Closed -$237K – 2567
2025
Q1 		$237K Buy
26,678
+6,085
+30% +$73.1K ﹤0.01% 2087
2024
Q4 		$282K Buy
20,593
+5,519
+37% +$102K ﹤0.01% 1953
2024
Q3 		$413K Sell
15,074
-170
-1% -$4.6K ﹤0.01% 1687
2024
Q2 		$373K Buy
15,244
+180
+1% +$3.95K ﹤0.01% 1674
2024
Q1 		$321K Sell
15,064
-11,512
-43% -$247K ﹤0.01% 1738
2023
Q4 		$509K Sell
26,576
-207
-0.8% -$3.58K ﹤0.01% 1729
2023
Q3 		$430K Buy
+26,783
New +$510K ﹤0.01% 1741
2022
Q3 		– Sell
-5,272
Closed -$96K – 3294
2022
Q2 		$96K Buy
5,272
+189
+4% +$3.92K ﹤0.01% 2218
2022
Q1 		$128K Buy
5,083
+2,581
+103% +$66.1K ﹤0.01% 2081
2021
Q4 		$69K Sell
2,502
-65
-3% -$1.88K ﹤0.01% 2424
2021
Q3 		$83K Buy
2,567
+41
+2% +$1.36K ﹤0.01% 2220
2021
Q2 		$77K Sell
2,526
-177
-7% -$5.11K ﹤0.01% 2217
2021
Q1 		$82K Buy
2,703
+2,558
+1,764% +$72.6K ﹤0.01% 2098
2020
Q4 		$3K Sell
145
-462
-76% -$7.46K ﹤0.01% 3011
2020
Q3 		$8K Buy
607
+70
+13% +$886 ﹤0.01% 2372
2020
Q2 		$6K Buy
+537
New +$7.63K ﹤0.01% 2352
2019
Q4 		– Sell
-537
Closed -$15K – 1500
2019
Q3 		$15K Buy
+537
New +$15.6K ﹤0.01% 1390

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CAPTRUST Financial Advisors's MYGN Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Myriad Genetics (MYGN) stake by 78% in Q2 2026, buying an estimated $50.1K and bringing the position to 25,261 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2971.

CAPTRUST Financial Advisors first reported a position in MYGN in Q3 2019 and has held it in 21 quarters since. The position peaked at $509K in Q4 2023. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • CAPTRUST Financial Advisors held 25,261 shares of Myriad Genetics worth $144K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 11,040 Myriad Genetics shares in Q2 2026, an estimated $50.1K.
  • Myriad Genetics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2971 holding.
  • CAPTRUST Financial Advisors first reported a position in Myriad Genetics in Q3 2019 and has held it in 21 quarters since.
  • CAPTRUST Financial Advisors's Myriad Genetics position peaked at $509K in Q4 2023.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.